Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flu/Bu/Cy Conditioning with Post-Transplant Cyclophosphamide for Lymphoid Malignancies
NCT01435447Phase 2Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Apr 2011
- Primary completion
- Jun 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, busulfan, cyclophosphamide in lymphoid malignancy, acute lymphoblastic leukemia (ALL), sponsored by Shanghai Jiao Tong University School of Medicine. Started Apr 2011; status: completed.
02
Drugs
fludarabinebusulfancyclophosphamide
03
Conditions
lymphoid malignancyacute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01435447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01435447.